Pages that link to "Q33855388"

The following pages link to The prevalence and analysis of risk factors for age-related macular degeneration: 18-year follow-up data from the Speedwell eye study, United Kingdom. (Q33855388):

Displaying 10 items.

• Experiences with developing and implementing a virtual clinic for glaucoma care in an NHS setting (Q36177066) (← links)
• Is spectral-domain optical coherence tomography essential for flexible treatment regimens with ranibizumab for neovascular age-related macular degeneration? (Q37351537) (← links)
• The Association between the Lipids Levels in Blood and Risk of Age-Related Macular Degeneration (Q37374027) (← links)
• The effect of CFH polymorphisms on the response to the treatment of age-related macular degeneration (AMD) with intravitreal ranibizumab (Q37407241) (← links)
• Prevalence of age-related macular degeneration in an elderly UK Caucasian population-The Bridlington Eye Assessment Project: a cross-sectional study (Q38915036) (← links)
• Bevacizumab versus Ranibizumab on As-Needed Treatment Regimen for Neovascular Age-Related Macular Degeneration in Turkish Patients (Q41915161) (← links)
• Improving care and increasing efficiency-challenges in the care of chronic eye diseases. (Q42733207) (← links)
• Genetic risk factors and age-related macular degeneration (AMD). (Q55551541) (← links)
• Ophthalmologic evaluation of severely obese patients undergoing bariatric surgery: A pilot, monocentric, prospective, open-label study. (Q64967315) (← links)
• Risk factors for progression of age-related macular degeneration (Q89888023) (← links)